Evidence map›Paper›PMID 34327505›Full record

ArticleAmerican journal of preventive cardiology2021

Race is not a risk factor: Reframing discourse on racial health inequities in CVD prevention.

Luke G Silverman-Lloyd, Naomi S Bishop, Jessica P Cerdeña

RetractedAbstract read
In one paragraph

Article in American journal of preventive cardiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. I am not your minority.Lancet regional health. Americas · 2023
    Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

  • Reinstatement · 2021-06-10Date of Article and/or Notice Unknown · Notice - Limited or No Information · Removed · Retract and Replace · Temporary Removal · · date of retraction unknown, html overwrite, date estimated from date modified on retracted pdf (https://web.archive.org/web/*/https://pdf.sciencedirectassets.com/777610/1-s2.0-S2666667721X00025/1-s2.0-S2666667721000404/*) article reinstated unknown date
5 · Who and what money

Authors and funding

3 authors.

Luke G Silverman-LloydUniversity of California San Francisco School of Medicine, San Francisco, CA, USA.
Naomi S BishopUniversity of Arizona at Phoenix, Phoenix, AZ, USA.
Jessica P CerdeñaYale School of Medicine, Yale University, 10 Sachem Street, New Haven, CT 06511, USA.

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Medical Scientist Training ProgramT32GM136651 · NIGMS · YALE UNIVERSITY · PI BARBARA I KAZMIERCZAK · 2020 to 2026
$16.5M
NCATS NIH HHS UL1 TR001863NIGMS NIH HHS T32 GM136651
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID34327505
PMCPMC8315343

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.